AAV-话题@MedSci

#AAV#

41篇内容 | 2680人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271875, encodeId=5b6912e187521, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=SCI TRANS MED：临床数据显示，脑部AAV疗法拯救婴儿致命遗传疾病, objectType=article, longId=204128, objectId=70122041280e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70122041280e, replyNumber=0, likeNumber=72, createdTime=2020-12-06, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70122041280e, moduleTitle=SCI TRANS MED：临床数据显示，脑部AAV疗法拯救婴儿致命遗传疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70122041280e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271874, encodeId=522212e187472, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Nat Biotechnol ：十年监测发现，更安全基因治疗载体AAV，竟有潜在致癌性, objectType=article, longId=203590, objectId=618120359083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=618120359083, replyNumber=0, likeNumber=77, createdTime=2020-11-22, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=618120359083, moduleTitle=Nat Biotechnol ：十年监测发现，更安全基因治疗载体AAV，竟有潜在致癌性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=618120359083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271873, encodeId=7fd412e1873b0, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Blood：AAV5基因治疗后人血浆中转基因产生的VIII因子的活性, objectType=article, longId=201705, objectId=db7d201e05c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db7d201e05c0, replyNumber=0, likeNumber=88, createdTime=2020-10-07, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db7d201e05c0, moduleTitle=Blood：AAV5基因治疗后人血浆中转基因产生的VIII因子的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db7d201e05c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271872, encodeId=9fc212e187262, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Brain ：“脑残”有得治？首例！基因载体AAVhu.32可矫正全脑的基因缺陷, objectType=article, longId=198602, objectId=83d81986023f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83d81986023f, replyNumber=0, likeNumber=77, createdTime=2020-08-03, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83d81986023f, moduleTitle=Brain ：“脑残”有得治？首例！基因载体AAVhu.32可矫正全脑的基因缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83d81986023f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271871, encodeId=77da12e1871bc, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=ASRS 2020：AAV-RPGR基因疗法治疗X-性连锁遗传性视网膜劈裂症，患者视力显着改善, objectType=article, longId=197733, objectId=eaff19e73351, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaff19e73351, replyNumber=0, likeNumber=74, createdTime=2020-07-20, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaff19e73351, moduleTitle=ASRS 2020：AAV-RPGR基因疗法治疗X-性连锁遗传性视网膜劈裂症，患者视力显着改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaff19e73351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271869, encodeId=45cf12e186916, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=SCI ADV：AAV基因疗法可解决骨关节炎和肥胖问题, objectType=article, longId=194356, objectId=f4381943567d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4381943567d, replyNumber=0, likeNumber=93, createdTime=2020-05-20, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4381943567d, moduleTitle=SCI ADV：AAV基因疗法可解决骨关节炎和肥胖问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4381943567d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271868, encodeId=7eae12e186810, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Ultragenyx宣布其AAV基因疗法DTX401，用于Ia型糖原性贮积病的1/2期确证研究组的阳性数据, objectType=article, longId=194314, objectId=5dae19431410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dae19431410, replyNumber=0, likeNumber=64, createdTime=2020-05-19, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dae19431410, moduleTitle=Ultragenyx宣布其AAV基因疗法DTX401，用于Ia型糖原性贮积病的1/2期确证研究组的阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dae19431410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271870, encodeId=c3af12e1870cb, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症, objectType=article, longId=192750, objectId=788f192e507d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788f192e507d, replyNumber=0, likeNumber=59, createdTime=2020-04-24, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788f192e507d, moduleTitle=FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788f192e507d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271867, encodeId=d94512e1867a0, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Janssen的遗传性视网膜疾病基因疗法AAV-RPGR，获得欧洲药品管理局PRIME称号, objectType=article, longId=189502, objectId=3dc618950238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc618950238, replyNumber=0, likeNumber=52, createdTime=2020-03-08, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc618950238, moduleTitle=Janssen的遗传性视网膜疾病基因疗法AAV-RPGR，获得欧洲药品管理局PRIME称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc618950238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271866, encodeId=b90012e18663c, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Gaucher病的AAV基因疗法取得新进展, objectType=article, longId=188010, objectId=770e18801063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=770e18801063, replyNumber=0, likeNumber=65, createdTime=2020-02-15, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=770e18801063, moduleTitle=Gaucher病的AAV基因疗法取得新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=770e18801063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271865, encodeId=af0212e186534, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Science：晴天霹雳！公认更安全基因治疗载体AAV，竟有潜在致癌性, objectType=article, longId=186091, objectId=93fe186091f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93fe186091f8, replyNumber=0, likeNumber=63, createdTime=2020-01-13, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93fe186091f8, moduleTitle=Science：晴天霹雳！公认更安全基因治疗载体AAV，竟有潜在致癌性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93fe186091f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271864, encodeId=bed612e1864ac, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病, objectType=article, longId=185592, objectId=01b9185592c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b9185592c1, replyNumber=0, likeNumber=104, createdTime=2020-01-04, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b9185592c1, moduleTitle=NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01b9185592c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271863, encodeId=ef9012e18638e, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Freeline公司肝脏靶向的AAV基因疗法，在临床前数据中展现出治疗戈谢病的潜力, objectType=article, longId=174979, objectId=9f701e4979d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f701e4979d0, replyNumber=0, likeNumber=56, createdTime=2019-07-09, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f701e4979d0, moduleTitle=Freeline公司肝脏靶向的AAV基因疗法，在临床前数据中展现出治疗戈谢病的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f701e4979d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271862, encodeId=160212e1862f7, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=PNAS：AAV2 / 9病毒疗法延迟ALS疾病发作, objectType=article, longId=174930, objectId=b2e61e493035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2e61e493035, replyNumber=0, likeNumber=90, createdTime=2019-07-08, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2e61e493035, moduleTitle=PNAS：AAV2 / 9病毒疗法延迟ALS疾病发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2e61e493035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271861, encodeId=dc8512e1861c0, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=治疗粘多糖贮积症的基因疗法LYS-SAF302 的II/III期临床试验AAVance正式开始, objectType=article, longId=160342, objectId=a54e16034284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a54e16034284, replyNumber=0, likeNumber=60, createdTime=2019-02-19, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a54e16034284, moduleTitle=治疗粘多糖贮积症的基因疗法LYS-SAF302 的II/III期临床试验AAVance正式开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a54e16034284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271860, encodeId=94be12e1860ef, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=FDA批准UniQure开展亨廷顿病的AAV基因治疗临床试验, objectType=article, longId=158975, objectId=56e61589e539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56e61589e539, replyNumber=0, likeNumber=67, createdTime=2019-01-28, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56e61589e539, moduleTitle=FDA批准UniQure开展亨廷顿病的AAV基因治疗临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56e61589e539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271859, encodeId=1d4b12e1859f4, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战, objectType=article, longId=146844, objectId=bc0d1468443f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0d1468443f, replyNumber=0, likeNumber=71, createdTime=2018-08-18, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0d1468443f, moduleTitle=Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0d1468443f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271858, encodeId=6ebd12e18581a, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=NEJM：重症血友病A患者的AAV5-VIII因子基因治疗, objectType=article, longId=124918, objectId=9605124918d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9605124918d9, replyNumber=0, likeNumber=105, createdTime=2017-12-30, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9605124918d9, moduleTitle=NEJM：重症血友病A患者的AAV5-VIII因子基因治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9605124918d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271857, encodeId=02ea12e185723, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Gene Ther：在rd1小鼠模型和灵长类视网膜外植体中重组AAV不同的倾向性研究！, objectType=article, longId=112493, objectId=b200112493e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b200112493e9, replyNumber=0, likeNumber=64, createdTime=2017-09-11, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b200112493e9, moduleTitle=Gene Ther：在rd1小鼠模型和灵长类视网膜外植体中重组AAV不同的倾向性研究！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b200112493e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271856, encodeId=5ccb12e185604, content=<a href='/topic/show?id=9fef169483' target=_blank style='color:#2F92EE;'>#AAV#</a>, objectTitle=Lancet：AAV2载体基因组表达VEGF中和蛋白sFLT01的安全性研究, objectType=article, longId=98925, objectId=dcf99892561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcf99892561, replyNumber=0, likeNumber=63, createdTime=2017-05-19, rootId=0, userName=xuqianhua, userId=8ba7103, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcf99892561, moduleTitle=Lancet：AAV2载体基因组表达VEGF中和蛋白sFLT01的安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcf99892561)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AAV

2020-05-29

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

SCI TRANS MED：临床数据显示，脑部AAV疗法拯救婴儿致命遗传疾病

2020-12-06

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Nat Biotechnol ：十年监测发现，更安全基因治疗载体AAV，竟有潜在致癌性

2020-11-22

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Blood：AAV5基因治疗后人血浆中转基因产生的VIII因子的活性

2020-10-07

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Brain ：“脑残”有得治？首例！基因载体AAVhu.32可矫正全脑的基因缺陷

2020-08-03

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

ASRS 2020：AAV-RPGR基因疗法治疗X-性连锁遗传性视网膜劈裂症，患者视力显着改善

2020-07-20

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

SCI ADV：AAV基因疗法可解决骨关节炎和肥胖问题

2020-05-20

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Ultragenyx宣布其AAV基因疗法DTX401，用于Ia型糖原性贮积病的1/2期确证研究组的阳性数据

2020-05-19

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症

2020-04-24

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Janssen的遗传性视网膜疾病基因疗法AAV-RPGR，获得欧洲药品管理局PRIME称号

2020-03-08

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Gaucher病的AAV基因疗法取得新进展

2020-02-15

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Science：晴天霹雳！公认更安全基因治疗载体AAV，竟有潜在致癌性

2020-01-13

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病

2020-01-04

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Freeline公司肝脏靶向的AAV基因疗法，在临床前数据中展现出治疗戈谢病的潜力

2019-07-09

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

PNAS：AAV2 / 9病毒疗法延迟ALS疾病发作

2019-07-08

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

治疗粘多糖贮积症的基因疗法LYS-SAF302 的II/III期临床试验AAVance正式开始

2019-02-19

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

FDA批准UniQure开展亨廷顿病的AAV基因治疗临床试验

2019-01-28

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战

2018-08-18

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

NEJM：重症血友病A患者的AAV5-VIII因子基因治疗

2017-12-30

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Gene Ther：在rd1小鼠模型和灵长类视网膜外植体中重组AAV不同的倾向性研究！

2017-09-11

xuqianhua (审核中...)

前往app查看评论内容

#AAV#

Lancet：AAV2载体基因组表达VEGF中和蛋白sFLT01的安全性研究

2017-05-19

科室
- - 订阅+
  - 更多科室
工具
服务